Microbial oil containing dha at sn-2 position and preparation method and uses therefor

专利摘要:
The present disclosure relates to microbial technology, and provides a microbial oil containing DHA at an sn—2 position, a preparation method and uses therefor. A weight percentage of DHA at the sn—2 position of triglyceride in the microbial oil is not less than 23%. The method for producing the microbial oil is carried out by inoculating Schizochytrium strains into a fermentation medium for fermentation. The Schizochytrium strains is assigned accession No.60733. The DHA at the sn—2 position of triglyceride is far more than the DHA at the sn—1 and sn—3 position of triglyceride, Which improves the absorption of the DHA in the microbial oil in human body and effectively facilitates the utilization of DHA in human body.
公开号:NL2026990A
申请号:NL2026990
申请日:2020-11-26
公开日:2021-08-26
发明作者:Liang Yun；Wang Shenjian；Cao Sheng
申请人:Qu hanpeng；
IPC主号:

专利说明:

MICROBIAL OIL CONTAINING DHA AT SN-2 POSITION ANDPREPARATION METHOD AND USES THEREFOR
TECHNICAL FIELD The present disclosure relates to microbial technology, and more particularly to a microbial oil containing DHA at an sn-2 position, and a preparation method and uses therefor.
BACKGROUND Docosahexaenoic acid (DHA) is a primary structural fatty acid in the brain and eyes. It accounts for 97% and 93% of all n-3 fatty acids in the brain and eyes, respectively. It has been reported that compared to triglycerides with random structures, triglycerides with a special structure that DHA is at the sn-2 position are easier to absorb. Meanwhile, other studies show that when people take in lipids with the special structure, a content of DHA in the brain is higher than that in other organs, whereas when people take in lipids with random structures, a content of DHA in the liver is highest, which indicates that triglycerides with different structures are different in fatty acid metabolism, in other words, the fatty acids at the sn-2 position can be more effectively absorbed than those at the sn-1 or sn-3 position. Pancreatic lipase, as a primary lipase enzyme, attaches a water- oil interface to hydrolyze dietary fat molecules. Meanwhile, pancreatic lipase only breaks down specific ester bonds at the sn-1 and sn-3 positions. Hydrolyzed by pancreatic lipase, fat molecules with triglyceride structure are converted into free fatty acids and monoglycerides. In the conversion, the free fatty acids are formed from the fatty acids at the sn-1 and sn-3 positions and hard to penetrate bile salt micelle and absorb, and the free fatty acids are then combined with calcium and magnesium ions in the intestine to form intestine soap salts and wasted, whereas the monoglycerides are formed from the fatty acids at the sn-3 position and easy to penetrate bile salt micelle and absorb. Therefore, the absorption rate of fatty acids at the sn-2 position in the human body is higher than that of the fatty acids at the sn-1 and sn-3 positions.
As consumers become more aware of the health impact of DHA, microbial oils, as primary resources of DHA, have been largely adopted in infant food and nutraceuticals, and their nutritional benefits are increasingly recognized by the public. Therefore, people are more and more concerned about the absorption rate of DHA in microbial oils. For now, DHA oils from microbial sources are mainly produced by fermentation using microorganisms such as Ukenella, Schizochytrium, Thraustochytrium, Cryptodinium, and yeast. However, the amount of DHAs at sn-2 positions of the triglyceride are far less than DHAs at the sn-1 and sn-3 positions of the triglyceride. Most of DHAs are formed into soap salts and wasted, which decreases the benefits of the microbial oils.
SUMMARY The object of the present disclosure is to provide a microbial oil containing DHA at an sn-2 position, a method for making the same, and an application of the same to solve the problem that fatty acids are hard to absorb by the human body for there are too many fatty acids at the sn-1 and sn-3 positions of triglyceride in those microbial oils. The microbial oil provided herein is produced by a fermentation using Schizochytrium, and a weight percentage of the DHA at the sn-2 position of triglyceride in the microbial oil is not less than 23%, improving the absorption of DHA in the human body.
In order to realize the above-mentioned object, the present disclosure provides a microbial oil containing DHA at an sn-2 position, and a weight percentage of the DHA at the sn-2 position of triglyceride in the microbial oil is not less than 23%.
The present disclosure further provides a method for producing the microbial oil mentioned above, comprising: inoculating Schizochytrium strains into a fermentation medium for fermentation; wherein the Schizochytrium strains is assigned accession No.60733.
In some embodiments, the fermentation medium comprises a carbon source, a nitrogen source, an inorganic salt, a trace element and a vitamin; and a fermentation is performed at pH 6-7.5 and 27-31°C for 4-8 days under a ventilation at 0.45-1.1 vvm, wherein a concentration of glutamate is at 5-15 g/L and a concentration of the carbon source is at 5-70 g/L.
In some embodiments, the method comprises:
activating the Schizochytrium strains in a shake flask to obtain an inoculum; inoculating the inoculum into a seed culture medium, and culturing the inoculum; and inoculating the inoculum into a fermentation medium for the fermentation.
In some embodiments, the activating process comprises: thawing the Schizochytrium strains stored in frozen glycerin in a tube; and inoculating the strains into a seed culture medium for a propagation.
In some embodiments, the activating process comprises: thawing the Schizochytrium strains stored in the frozen glycerin in a tube; inoculating the strains into the sterilized seed culture medium by a sterile straw; and culturing the strains at 27.5-28.5°C for 48-72 hours at a speed of 150-200 r/min, wherein in the seed culture medium, a concentration of the carbon source is 30-50 g/L; a concentration of the nitrogen source is 25-45 g/L; a concentration of the inorganic salt is 25-40 g/L; a concentration of the trace element is 0.015-0.025 g/L; and a concentration ofthe vitamin is 0.01-0.02 g/L.
In some embodiments, the carbon source is selected from the group consisting of glucose, sucrose and a combination thereof, the nitrogen source is selected from the group consisting of sodium glutamate, yeast powder, yeast extract and a combination thereof, the inorganic salt is selected from the group consisting of calcium salt, phosphate, potassium salt, sodium salt, magnesium salt, ammonium salt and a combination thereof; the trace element is selected from the group consisting of nickel, copper, molybdenum, cobalt, zinc, iron, manganese and a combination thereof; and the vitamin is selected from the group consisting of vitamin By, vitamin B12, vitamin Bs, calcium pantothenate, biotin and a combination thereof.
In some embodiments, the method further comprising: breaking walls of a fermentation product; and extracting an oil product from the fermentation product.
The present disclosure further provides a microbial oil produced by any one of the methods mentioned above, and in the microbial oil, a weight percentage of DHA at the sn-2 position of triglyceride in the microbial oil is not less than 23% and a weight percentage of triglyceride DHA is not less than 38%.
The present disclosure further provides a use of the microbial oil produced by any one of the methods mentioned above in food, wherein the food is preferably infant formulas, nutraceuticals or health food.
According to the technical solutions mentioned above, the present disclosure, by a fermentation using Schizochytrium strains, produces a microbial oil containing DHA, wherein the DHA at the sn-2 position of triglyceride is far more than the DHA at the sn- 1 and sn-3 position of triglyceride, which improves the absorption of DHA in the microbial oil in human body and effectively facilitates the utilization of DHA in the human body.
The features and beneficial effects will be further described in detail below with reference to the embodiments.
Deposit of microorganisms The Schizochytrium strains of present disclosure assigned GDMCC No. 60733 was deposited on August 8, 2019 with Guangdong Microbial Culture Collection Center (GDMCC, Guangdong Institute of Microbiology, 5th Floor, Building 59, No. 100 Xianlie Middle Road, Guangzhou, 510070, China).
DETAILED DESCRIPTION OF EMBODIMENTS It should be noted that endpoints and values within ranges disclosed herein are only exemplary, and are intended to include any values close to these values. Any possible combination of numerical values within the range to form one or more new ranges should be considered to be expressly disclosed in this disclosure.
In a first aspect, the present disclosure provides a microbial oil containing DHA at an sn-2 position, and a weight percentage of the DHA at the sn-2 position of triglyceride in the microbial oil is not less than 23%.
In a second aspect, the present disclosure further provides a method for producing the microbial oil mentioned above. Schizochytrium strains are inoculated into a fermentation medium for fermentation, and an accession number of the Schizochytrium strains is assigned as No.60733.
After the fermentation, the Schizochytrium strains produce a microbial oil containing DHA, and the fermentation, without special requirements, is for a propagation of the Schizochytrium strains.
5 The fermentation conditions, including pH, temperature, time, ventilation, carbon source and nitrogen source, are all generally used and have no special requirements. In order to increase a yield of the fermentation, in some embodiments, the fermentation medium includes carbon source, nitrogen source, inorganic salt, trace element and vitamin, and the fermentation is performed at pH 6-7.5 and 27-31°C for 4-8 days under a ventilation at 0.45-1.1 vvm, wherein a concentration of glutamate is at 5-15 g/L and a concentration of the carbon source is at 5-70 g/L.
During the fermentation, the addition of the carbon source and the nitrogen source is according to adjustments of carbon-to-nitrogen ratios. When the fermentation is close to a terminal, no carbon source is supplied into the medium so that the residual carbohydrate source is reduced to 0. In this way, an auxotroph condition is formed by adjusting the carbon-to-nitrogen ratios to improve the oil production of the Schizochytrium strains In order to increase a yield of the fermentation, in some embodiments, the Schizochytrium strains is activated in a shake flask to obtain an inoculum, and the inoculum is inoculated and cultured in a seed culture medium, and culturing the inoculum, then the inoculum is inoculated into a fermentation medium for the fermentation;.
In some embodiments, in the activating process, the Schizochytrium strains stored in frozen glycerin in a tube are thawed and inoculated into a seed culture medium for a propagation.
Preferably, in the activating process, the Schizochytrium strains stored in frozen glycerin in a tube are thawed and inoculated into a sterilized seed culture medium by a sterile straw. The strain is cultured at 27.5-28.5°C for 48-72 hours at a speed of 150-200 r/min, wherein in the seed culture medium, a concentration of carbon source is 30-50 g/L; a concentration of nitrogen source is 25-45 g/L; a concentration of inorganic salt is 25-40 g/L; a concentration of trace element is 0.015-0.025 g/L; and a concentration of vitamin is 0.01-0.02 g/L. Specifically, the strains in one tube are inoculated into 4-6 flasks with a storage capacity of 500 mL, and each flask contains 200-300 mL of the seed culture medium. In some embodiments, the carbon source is glucose, sucrose or substrate that can be supplied as carbon sources, and the nitrogen source is or sodium glutamate, yeast powder, yeast extract or any substrate that can supply nitrogen sources. Preferably, the carbon source is selected from the group consisting of glucose, sucrose and a combination thereof; the nitrogen source is selected from the group consisting of sodium glutamate, yeast powder, yeast extract and a combination thereof; the inorganic salt is selected from the group consisting of calcium salt, phosphate, potassium salt, sodium salt, magnesium salt, ammonium salt and a combination thereof, the trace element is selected from the group consisting of nickel, copper, molybdenum, cobalt, zinc, iron, manganese and a combination thereof, and the vitamin is selected from the group consisting of vitamin By, vitamin B12, vitamin Be, calcium pantothenate, biotin and a combination thereof.
The present disclosure may further process the above-mentioned fermentation product to obtain a microbial oil. The processing, without special requirements, is for extracting the microbial oil from the fermentation product. In order to improve the production of the microbial oil, during the processing, walls of the fermentation product are broken, and an oil product is extracted the resulting product.
In a third aspect, the present disclosure provides a microbial oil produced by any one of the methods mentioned above, and a weight percentage of DHA at the sn-2 position of triglyceride in the microbial oil is not less than 23% and a weight percentage of triglyceride DHA in the microbial oil is not less than 38%.
In a fourth aspect, the present disclosure further provides a use of the microbial oil produced by any one of the methods mentioned above in food, and food is preferably infant formulas, nutraceuticals or health food.
The present disclosure will be further described in detail below accompanying the embodiments. In the embodiments, a content of DHA and a fatty acid composition in a microbial oil are detected according to GB26400-2011 and Standard Test Method for Determination of Fatty Acids in Food, GB5009. 168-2016, respectively. A weight percentage of the DHA at the sn-2 position of triglyceride in the microbial oil is detected according to Animal and Vegetable Fats and Oils—Determination of the Composition of Fatty Acids in the 2- position of the Triglyceride Molecules, GB/T24984-2010/ISO6800:1997. A weight percentage of the DHA at the sn-1 and sn-3 positions of triglyceride in the microbial oil is calculated according to a 1,3-random-2-random distribution theory based on the analyses of all fatty acids in the sample and the fatty acids at sn-2 position. The absorption rate of DHA in the human body is detected by an efficacy trial, where male and female volunteers are required to take in the microbial oil produced by the method of the present disclosure, and then have their blood drawn to determine a content of the DHA at the sn- 2 position in the blood to calculate the absorption rate of DHA. Schizochytrium strams are provided by the China Center of Industrial Culture Collection, and the accession number is CICC 11091s. The glucose, sucrose, yeast powder, sodium glutamate, yeast extract, sodium chloride, magnesium sulfate, calcium chloride, potassium dihydrogen phosphate, nickel sulfate, copper sulfate, sodium molybdate, cobalt chloride, zinc sulfate, ferrous sulfate, manganese chloride, vitamin Bi, vitamin B>, vitamin Bs, calcium pantothenate, biotin, sodium bicarbonate, sodium sulfate, ammonium sulfate and potassium chloride are all commercially available. In the embodiments, a formula of a trace-element solution is: 2 g/L of nickel sulfate,
1.9 g/L of copper sulfate, 0.04 g/L of sodium molybdate, 2.8 g/L. of manganese chloride,
0.04 g/L of cobalt chloride, 3.2 g/L of zinc sulfate and 9g /L of ferrous sulfate. A formula of a vitamin solution is: 10.3 g/L of vitamin By, 0.16 g/L of vitamin B12, 3.2 g/L of calcium pantothenate and 0.008 g/L of biotin. Example 1 30 L fermentation and production using Schizochytrium strains A formula of a seed culture medium was: 40 g/L of glucose, 31 g/L of sodium glutamate, 19 g/L of sodium chloride, 5.8 g/L of yeast extract, 8 g/L of magnesium sulfate,
5.7 g/L of potassium dihydrogen phosphate, 1 g/L of trace elements and 1 g/L of vitamins. A formula of a seed-tank culture medium was: 30 g/L of glucose, 6.3 g/L of sodium glutamate, 1.45 g/L of sodium chloride, 8.3 g/L of yeast extract, 8.3 g/L yeast powder,
5.18 g/L magnesium sulfate, 1.66 g/L potassium dihydrogen phosphate, 0.25 g/L calcium chloride, 0.25 g/L sodium bicarbonate, 9.34 g/L sodium sulfate, 1.04 g/L ammonium sulfate, 0.83 g/ potassium chloride L, 1 g/L of trace elements, 1 g/L of vitamins and 0.3 g/L of a defoamer. A formula of a fermentation medium was: 50 g/L of glucose, 15 g/L of sodium glutamate, 2.6 g/L of sodium chloride, 10.9 g/L of yeast extract, 5.8 g/L of magnesium sulfate, 2.4 g/L of potassium dihydrogen phosphate, 0.25 g/L of calcium chloride, 0.22 g/L of sodium bicarbonate, 3.62 g/L of sodium sulfate, 1.13 g/L of ammonium sulfate,
0.94 g/L of potassium chloride, 1.1 g/L of trace elements, 1.1 g/L of vitamins and 0.19 g/L of a defoamer.
The specific steps of the fermentation were shown as follows.
(1) Ordinary Schizochytrium strains and Schizochytrium strains used herein (Accession No. 60733) were activated, respectively. Schizochytrium strains stored in each tube containing frozen glycerin were thawed and inoculated into four shake flasks containing 200 mL of the seed culture medium, and cultured on a shaker at 28°C for 48 hours at a speed of 180 r/min to obtain an inoculum.
(2) 3% (v/v) of the inoculum obtained from step (1) was inoculated in a shake flask containing 200 mL of the seed culture medium, and cultured on a shaker at 28°C for 72 hours at a speed of 180 r/min for a propagation.
(3) 200 mL of the inoculum obtained from step (2) was inoculated in a seed tank containing 3 L of the seed-tank culture medium, and cultured at 28°C for 50 hours at a speed of 180 r/min. A ventilation was 0.6 vvm, and a pressure of the seed tank was 0.03 MPa.
(4) All of the inoculum obtained from step (3) was inoculated in a fermentor containing 14 L of the fermentation medium, and cultured at pH 6.8 and 29°C for 5-6 days at a speed of 140 r/min. Ventilation: 0.95 vvm. Pressure of the fermentor: 0.03 MPa.
During the fermentation, a sterile glucose solution (250 g/L) and a sterile sodium glutamate solution (250 g/L) were added into the fermentor in fed-batch to maintain a concentration of glutamate at 5-8 g/L. and a concentration of carbon source at 10-23 g/L.
After 96 hours of the fermentation, the supply of carbon source and glutamate was stopped to obtain a fermentation broth.
(5) SL of the fermentation broth obtained from step (4) was subjected to a cell wall disruption by enzyme, and then separated into a water phase, a solid phase, and an oil phase with a lab-level high speed centrifuge to obtain a microbial oil. (6) The microbial oil obtained from step (5) was analyzed to obtain a content of DHA, a fatty acid composition and a weight percentage of DHA at the sn-2 position of triglyceride therein. The results were showed in Table 1. Table 1 Parameters of the microbial oils in Example | Ordinary Schizochytrium strains Schizochytrium strains used herein emt | |e
21.97 43.24 position of triglyceride, % Weight percentage of DHA at sn-1 and wees
56.98 47.55 sn-2 positions of triglyceride, % Example 2 100 L fermentation and production using Schizochytrium strains A formula of a seed culture medium was: 30 g/L of glucose, 20 g/L of sodium glutamate, 15 g/L of sodium chloride, 5 g/L of yeast extract, 6 g/L of magnesium sulfate, 4 g/L of potassium dihydrogen phosphate, 0.8 g/L of trace elements and 0.75 g/L of vitamins. A formula of a seed-tank culture medium was: 25 g/L of glucose, 5.5 g/L of sodium glutamate, 1.1 g/L of sodium chloride, 7 g/L of yeast extract, 7 g/L of yeast powder, 4 g/L of magnesium sulfate, 1.2 g/L of potassium dihydrogen phosphate, 0.15 g/L of calcium chloride, 0.15 g/L of sodium bicarbonate, 7 g/L of sodium sulfate, 0.8 g/L of ammonium sulfate, 0.6 g/L of potassium chloride, 0.8 g/L of trace elements, 0.75 g/L vitamins and
0.2 g/L of a defoamer.
A formula of a fermentation medium was: 30 g/L of glucose, 10 g/L of sucrose, 12 g/L of sodium glutamate, 2 g/L of sodium chloride, 9 g/L of yeast extract, 4.5 g/L of magnesium sulfate, 2 g/L of potassium dihydrogen phosphate, 0.2 g/L of calcium chloride,
0.2 g/L of sodium bicarbonate, 2.8 g/L of sodium sulfate, 1 g/L. of ammonium sulfate, 0.8 g/L of potassium chloride, 0.9 g/L of trace elements, 0.9 g/L of vitamins and 0.15 g/L of a defoamer.
(1) Ordinary Schizochytrium strains and Schizochytrium strains used herein (Accession No. 60733) were activated, respectively. Schizochytrium strains stored in each tube containing frozen glycerin were thawed and inoculated into five shake flasks containing 200 mL of the seed culture medium, and cultured on a shaker at 28.5°C for 72 hours at a speed of 150 r/min to obtain an inoculum.
(2) Two shake flasks of the inoculum obtained from step (1) was inoculated into five shake flasks containing 200 mL of the seed culture medium, and cultured on a shaker at 28°C for 48 hours at a speed of 150 r/min.
(3) 400 mL of the inoculum obtained from step (2) was inoculated in a seed tank containing 6 L of the seed-tank culture medium, and cultured at 28°C for 48 hours at a speed of 150 r/min. A ventilation was 0.5 vvm, and a pressure of the seed tank was 0.03 MPa.
(4) All of the inoculum obtained from step (3) was inoculated in a fermentor containing 45 L of the fermentation medium, and cultured at 28-29°C for 5-6 days at a speed of 90-120 r/min. Ventilation: 0.5-0.8 vvm. Pressure of the fermentor: 0.03 MPa. During the fermentation, a sterile glucose solution (250 g/L) and a sterile sodium glutamate solution (250 g/L) were added into the fermentor in fed-batch to maintain a concentration of glutamate at 8-12 g/L and a concentration of carbon source at 40-65 g/L. After 96 hours of the fermentation, the supply of carbon source and glutamate was stopped to obtain a fermentation broth.
(5) 10 L of the fermentation broth obtained from step (4) was subjected to a cell wall disruption by enzyme, and then separated into a water phase, a solid phase, and an oil il phase with a lab-level high speed centrifuge to obtain a microbial oil.
(6) The microbial oil obtained from step (5) was analyzed to obtain a content of DHA, a fatty acid composition and a weight percentage of DHA at the sn-2 position of triglyceride therein. The results were showed in Table 2.
Table 2 Parameters of the microbial oils in Example 2 Ordinary Schizochytrium strains Schizochytrium strains used herein Stearic acid (C18:0), g/100g Oleic acid (C18:1). g/100g Weight percentage of DHA at sn-2 ae ae
22.76 43.68 position of triglyceride, % Weight percentage of DHA at sn-1 and ees
57.37 46.68 sn-2 positions of triglyceride, % Example 3 45 m industrial fermentation and production using Schizochytrium strains A formula of a seed culture medium was: 50 g/L of glucose, 35 g/L of sodium glutamate, 22 g/L of sodium chloride, 10 g/L of yeast extract, 10 g/L of magnesium sulfate, 8 g/L of potassium dihydrogen phosphate, 1.4 g/L of trace elements and 1.5 g/L of vitamins.
A formula of a primary-seed-tank culture medium was: 35 g /L of glucose, 8 g/L of sodium glutamate, 1.9 g/L of sodium chloride, 10 g/L of yeast extract, 10 g/L of yeast powder, 6 g/L of magnesium sulfate, 2.1 g/L of potassium dihydrogen phosphate, 0.4 g/L of calcium chloride, 0.4 g/L of sodium bicarbonate, 12 g/L of sodium sulfate, 1.3 g/L of ammonium sulfate, 1.1 g/L of potassium chloride, 1.2 g/L of trace elements, 1.2 g/L vitamins and 0.4 g/L of a defoamer.
A formula of a secondary-seed-tank culture medium was: 50 g/L of glucose, 5.65 g/L of sodium glutamate, 1.3 g/L of sodium chloride, 5.65 g/L of yeast extract, 4.65 g/L of magnesium sulfate, 1.49 g/L of potassium dihydrogen phosphate, 0.22 g/L of calcium chloride, 0.22 g/L. of sodium bicarbonate, 8.39 g/L. of sodium sulfate, 0.93 g/L of ammonium sulfate, 0.74 g/L of potassium chloride, 0.93 g/L of trace elements, 0.93 g/L of vitamins and 0.3 g/L of a defoamer.
A formula of a fermentation medium was: 40 g/L of glucose, 20 g/L of sucrose, 20 g/L of sodium glutamate, 3.2 g/L of sodium chloride, 12 g/L of yeast extract, 7 g/L of magnesium sulfate, 3 g/L of potassium dihydrogen phosphate, 0.4 g/L of calcium chloride,
0.3 g/L of sodium bicarbonate, 4.5 g/L of sodium sulfate, 1.5 g/L of ammonium sulfate,
1.2 g/L of potassium chloride, 1.6 g/L of trace elements and 1.6 g/L vitamins.
The specific steps of the fermentation were shown as follows.
(1) Ordinary Schizochytrium strains and Schizochytrium strains used herein (Accession No. 60733) were activated, respectively. Schizochytrium strains stored in each tube containing frozen glycerin were thawed and inoculated into six shake flasks containing 200 mL of the seed culture medium, and cultured on a shaker at 28°C for 60 hours at a speed of 180 r/min to obtain an inoculum.
(2) Two shake flasks of the inoculum obtained from step (1) was inoculated into five flasks containing 200 mL of the seed culture medium, and cultured on a shaker at 28+0.5°C for 60 hours at a speed of 180 r/min for a propagation.
(3) 1L of the inoculum obtained from step (2) was inoculated in a primary seed tank containing 500 L of the primary-seed-tank culture medium sterilized and cooled to below 40°C, and cultured at pH 6.8, 28+0.5°C for 55 hours at a speed of 150 r/min.
(4) All of the inoculum obtained from step (3) was aseptically inoculated in a secondary seed tank containing 6 m® of the secondary-seed-tank culture medium sterilized and cooled to below 40°C, and cultured at pH 6.8, 28+0.5°C for 18 hours at a speed of 150 r/min.
(5) All of the inoculum obtained from step (4) was inoculated in a fermentor containing 22 m of the fermentation medium sterilized and cooled to below 40°C, and cultured at pH 7.5 and 2820.5°C for 5 days at a speed of 100 r/min. Ventilation: 1.0 vvm.
During the fermentation, a sterile glucose solution (250 g/L) and a sterile sodium glutamate solution (250 g/L) were added into the fermentor in fed-batch to maintain a concentration of glutamate at 12-15 g/L and a concentration of carbon source at 55-70 g/L. After 96 hours of the fermentation, the supply of carbon source and glutamate was stopped to obtain a fermentation broth.
(6) The fermentation broth was subjected to a cell wall disruption by enzyme, preheated to 85-90°C, and then separated with a triple-phase centrifuge to obtain a microbial oil.
(7) The microbial oil obtained from step (6) was analyzed to obtain a content of DHA, a fatty acid composition of and a weight percentage of DHA at the sn-2 position of triglyceride therein. The results were showed in Table 3. Table 3 Parameters of the microbial oils in Example 3 Ordinary Schizochytrium strains Schizochytrium strains used herein DHA (C22:6), g/100g 45,768 Docosapentaenoic acid (C22:5), g/100g Crees | me |e
22.148 43.96 position of triglyceride, % rl EE
54.56 46.33 sn-2 positions of triglyceride, % The above-mentioned embodiments are only preferred embodiments, and not intend to limit the scope of the present invention. It should be noted that variations and modifications can be made without departing from the spirit of the invention should fall in the scope of the present invention.

权利要求:
Claims (10)
[1]
A microbial oil comprising DHA at an sn-2 position, characterized in that in the microbial oil, a weight percentage of DHA at the sn-2 position of triglyceride is not less than 23%.
[2]
A method for producing the microbial oil according to claim 1, characterized by : inoculating Schizochytrium strains into a fermentation medium for fermentation; with the Schizochytrium strains assigned accession number 60733.
[3]
Process according to claim 2, characterized in that the fermentation medium comprises a carbon source, a nitrogen source, an inorganic salt, a trace element and a vitamin; and the fermentation is carried out at pH 6-7.5 and 27-31°C for 4-8 days under ventilation at 0.45-1.1 vv; wherein a concentration of flutamine is 5-15 g/l and a concentration of the carbon source is 5-70 g/l.
[4]
A method according to claim 2 or 3, characterized in that the method comprises: activating the Schizochytrium strains in a shaker bottle to obtain an inoculum; inoculating the inoculum into a seed culture medium and culturing the unoculum; and inoculating the inoculum into the fermentation medium for the fermentation.
[5]
A method according to claim 4, characterized in that the activation process comprises: thawing the Schizochytrium strains stored in frozen glycerin in one tube, and; inoculating the strains into a seed culture medium for propagation.
[6]
A method according to claim 4 or 5, characterized in that the activation process comprises: thawing the Schizochytrium strains stored in frozen glycerin in a tube, and;
inoculating the strains into the sterilized culture medium with a sterile straw; and culturing the strains at 27.5-28.5 °C for 48-72 hours at a rate of 150-200 rpm, wherein in the culture medium the concentration of the carbon source is 30-50 g/L; a concentration of the nitrogen source is 25-45 g/l; a concentration of the inorganic salt is 25-40 g/l; a concentration of the trace element is 0.015-0.025 g/l; and a concentration of the vitamin is 0.01-0.02 g/l.
[7]
A method according to claim 3 or 6, characterized in that the carbon source is selected from the group consisting of glucose, sucrose and a combination thereof; the nitrogen source is selected from the group consisting of sodium glutamate, yeast powder, yeast extract, and a combination thereof; the inorganic salt is selected from the group consisting of calcium salt, phosphate, potassium salt, sodium salt, magnesium salt, ammonium salt and a combination thereof; the trace element 1s selected from the group consisting of nickel, copper, molybdenum, cobalt, zinc, iron, manganese and a combination thereof; and the vitamin is selected from the group consisting of vitamin B1, vitamin B12, vitamin B6, calcium pantothenate, biotin, and a combination thereof.
[8]
A method according to any one of claims 2-7, characterized in that the method further comprises: breaking walls of a fermentation product, and; extracting an oil product from the fermentation product.
[9]
A microbial oil produced by the method according to any one of claims 2-8, characterized in that a weight percentage of DHA at the sn-2 position of triglyceride in the microbial oil is not less than 23%, and a weight percentage of triglyceride DHA in the microbial oil is not less than 38%.
[10]
Use of the microbial oil according to claim 9 in food, wherein the food is preferably infant formula, nutraceuticals or health food

类似技术:

---

公开号 | 公开日 | 专利标题

---

Athenaki et al.2018|Lipids from yeasts and fungi: physiology, production and analytical considerations

---

Bharathiraja et al.2017|Microbial oil–a plausible alternate resource for food and fuel application

---

Gonçalves et al.2014|Yarrowia lipolytica and its multiple applications in the biotechnological industry

---

Carsanba et al.2018|Production of oils and fats by oleaginous microorganisms with an emphasis given to the potential of the nonconventional yeast Yarrowia lipolytica

---

Liang et al.2010|Use of sweet sorghum juice for lipid production by Schizochytrium limacinum SR21

---

Unagul et al.2007|Coconut water as a medium additive for the production of docosahexaenoic acid | by Schizochytrium mangrovei Sk-02

---

Sijtsma et al.2004|Biotechnological production and applications of the ω-3 polyunsaturated fatty acid docosahexaenoic acid

---

US7989195B2|2011-08-02|Heterotrophic algal high cell density production method and system

---

US20070054384A1|2007-03-08|Method for the cultivation of microorganisms of the genus thraustochytriales by using an optimized low salt medium

---

Saygün et al.2014|Effects of different oil sources and residues on biomass and metabolite production by Yarrowia lipolytica YB 423-12

---

AU2020277167B2|2022-02-03|Microbial oil containing ara at sn-2 position and preparation method and uses therefor

---

Sijtsma et al.2010|Alternative carbon sources for heterotrophic production of docosahexaenoic acid by the marine alga Crypthecodinium cohnii

---

US8609397B2|2013-12-17|Method for preserving a microorganism

---

Dedyukhina et al.2011|Biosynthesis of arachidonic acid by micromycetes

---

NL2026990A|2021-08-26|Microbial oil containing dha at sn-2 position and preparation method and uses therefor

---

Patel et al.2017|Synchronized nutrient stress conditions trigger the diversion of CDP-DG pathway of phospholipids synthesis towards de novo TAG synthesis in oleaginous yeast escalating biodiesel production

---

Xu et al.2018|Fed-batch fermentation of Yarrowia lipolytica using defatted silkworm pupae hydrolysate: a dynamic model-based approach for high yield of lipid production

---

Bagul et al.2020|Effect of sequential recycling of spent media wastewater on docosahexaenoic acid production by newly isolated strain Aurantiochytrium sp. ICTFD5

---

AU2020277168B2|2022-02-24|Microbial oil containing dha at sn-2 position and preparation method and uses therefor

---

CN106318984B|2020-11-17|Method for preparing fatty acid glyceride by oleaginous microorganisms, glyceride and application thereof

---

Chaisawang et al.2012|Metabolic networks and bioenergetics of Aurantiochytrium sp. B-072 during storage lipid formation

---

Ghazani et al.2021|Microbial lipids for foods

---

Akpinar-Bayizit et al.2016|A Research on whey as a renewable substrate for single cell oil production by Saprolegnia diclina

---

CN104946691A|2015-09-30|Method for producing DHA-containing oil through fermentation by utilizing schizochytrium limacinum

---

CN105331670A|2016-02-17|Mixed fermentation method for schizochytrium sp. and crypthecodinium cohnii

同族专利:

---

公开号 | 公开日

---

EP3896167A1|2021-10-20|

---

CN110846346A|2020-02-28|

---

AU2020277168A1|2021-06-10|

---

WO2021104165A1|2021-06-03|

---

US20210340583A1|2021-11-04|

---

CN110846346B|2021-06-22|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

US20040052837A1|2002-06-27|2004-03-18|William Stillwell|Lipid conjugated anti-cancer drugs and methods of use thereof|

---

US9265745B2|2005-12-21|2016-02-23|Brudy Technology S.L.|Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage|

---

EP2734626B1|2011-07-21|2020-12-16|DSM IP Assets B.V.|Microbial oils enriched in polyunsaturated fatty acids|

---

CN103725721B|2013-12-20|2015-06-10|润科生物工程（福建）有限公司|Structural grease containing rich docosahexaenoic acid and preparation method thereof|

---

CN109247397A|2018-09-18|2019-01-22|湖北福星生物科技有限公司|A kind of Sn-2 Structure grease and preparation method thereof rich in docosahexaenoic acid|

---

CN110846346B|2019-11-26|2021-06-22|瞿瀚鹏|Microbial oil rich in Sn-2 DHA, and preparation method and application thereof|CN110846346B|2019-11-26|2021-06-22|瞿瀚鹏|Microbial oil rich in Sn-2 DHA, and preparation method and application thereof|

法律状态:

优先权:

---

申请号 | 申请日 | 专利标题

---

CN201911175787.4A|CN110846346B|2019-11-26|2019-11-26|Microbial oil rich in Sn-2 DHA, and preparation method and application thereof|

---